211 related articles for article (PubMed ID: 25455729)
1. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.
Roshan-Moniri M; Hsing M; Butler MS; Cherkasov A; Rennie PS
Cancer Treat Rev; 2014 Dec; 40(10):1137-52. PubMed ID: 25455729
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing by nuclear orphan receptors.
Zhang Y; Dufau ML
Vitam Horm; 2004; 68():1-48. PubMed ID: 15193450
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of orphan nuclear receptors in prostate cancer.
Wu D; Cheung A; Wang Y; Yu S; Chan FL
Biochim Biophys Acta; 2016 Aug; 1866(1):23-36. PubMed ID: 27264242
[TBL] [Abstract][Full Text] [Related]
4. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.
Safe S; Jin UH; Hedrick E; Reeder A; Lee SO
Mol Endocrinol; 2014 Feb; 28(2):157-72. PubMed ID: 24295738
[TBL] [Abstract][Full Text] [Related]
5. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.
Garattini E; Bolis M; Gianni' M; Paroni G; Fratelli M; Terao M
Oncotarget; 2016 Jul; 7(27):42661-42682. PubMed ID: 26894976
[TBL] [Abstract][Full Text] [Related]
6. The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element.
Yu RN; Ito M; Jameson JL
Mol Endocrinol; 1998 Jul; 12(7):1010-22. PubMed ID: 9658405
[TBL] [Abstract][Full Text] [Related]
7. Structures and regulation of non-X orphan nuclear receptors: A retinoid hypothesis.
Zhi X; Zhou XE; Melcher K; Xu HE
J Steroid Biochem Mol Biol; 2016 Mar; 157():27-40. PubMed ID: 26159912
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of liver X receptors and their ligands in cancer.
Lin CY; Vedin LL; Steffensen KR
Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
[TBL] [Abstract][Full Text] [Related]
10. Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.
Riggins RB; Mazzotta MM; Maniya OZ; Clarke R
Endocr Relat Cancer; 2010 Sep; 17(3):R213-31. PubMed ID: 20576803
[TBL] [Abstract][Full Text] [Related]
11. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
Xiao L; Xie X; Zhai Y
Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator.
Nakamura Y; Suzuki T; Arai Y; Sasano H
Endocr J; 2009; 56(1):39-44. PubMed ID: 18827407
[TBL] [Abstract][Full Text] [Related]
13. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis.
Shibata H; Ikeda Y; Mukai T; Morohashi K; Kurihara I; Ando T; Suzuki T; Kobayashi S; Murai M; Saito I; Saruta T
Mol Genet Metab; 2001; 74(1-2):206-16. PubMed ID: 11592817
[TBL] [Abstract][Full Text] [Related]
15. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
[TBL] [Abstract][Full Text] [Related]
16. The orphan nuclear receptors in cancer and diabetes.
Ranhotra HS
J Recept Signal Transduct Res; 2013 Aug; 33(4):207-12. PubMed ID: 23527960
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor as a drug target for the treatment of breast cancer.
Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
[TBL] [Abstract][Full Text] [Related]
18. The retinoid X receptor response element in the human aldehyde dehydrogenase 2 promoter is antagonized by the chicken ovalbumin upstream promoter family of orphan receptors.
Pinaire J; Hasanadka R; Fang M; Chou WY; Stewart MJ; Kruijer W; Crabb D
Arch Biochem Biophys; 2000 Aug; 380(1):192-200. PubMed ID: 10900149
[TBL] [Abstract][Full Text] [Related]
19. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization.
Wu Q; Li Y; Liu R; Agadir A; Lee MO; Liu Y; Zhang X
EMBO J; 1997 Apr; 16(7):1656-69. PubMed ID: 9130711
[TBL] [Abstract][Full Text] [Related]
20. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
